BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37489937)

  • 1. Detection of transient abnormal myelopoiesis blasts in a liver biopsy specimen by double-immunostaining for full-length GATA1 and CD42b.
    Haba A; Imaizumi Y; Hayashi D; Yasue S; Otsuka H; Endo S; Ozeki M; Kobayashi K; Miyazaki T; Hara A; Ohnishi H
    Hematology; 2023 Dec; 28(1):2240135. PubMed ID: 37489937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
    Watanabe K
    Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two patients of trisomy 21 with transient abnormal myelopoiesis with hypereosinophilia without blasts in peripheral blood smears.
    Okamoto T; Nagaya K; Sugiyama T; Aoyama A; Nii M; Azuma H
    Pediatr Hematol Oncol; 2021 Mar; 38(2):168-173. PubMed ID: 33150826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations.
    Nakashima MO; Shetty S; Chicka M; Flagg A; Eng C; Cotta CV
    Pediatr Blood Cancer; 2015 Feb; 62(2):353-355. PubMed ID: 25175265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants.
    Orozco-Vela M; Corona-Rivera A; Cruz-Osorio RM; Mendoza-Maldonado L; Márquez-Mora A; Barba-Barba CC; Peña-Padilla C; Baldomero-López A; Bobadilla-Morales L; Corona-Rivera JR
    Am J Med Genet A; 2020 Sep; 182(9):2085-2093. PubMed ID: 32681702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
    Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
    Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
    Toki T; Kanezaki R; Kobayashi E; Kaneko H; Suzuki M; Wang R; Terui K; Kanegane H; Maeda M; Endo M; Mizuochi T; Adachi S; Hayashi Y; Yamamoto M; Shimizu R; Ito E
    Blood; 2013 Apr; 121(16):3181-4. PubMed ID: 23440243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia.
    Kanezaki R; Toki T; Terui K; Xu G; Wang R; Shimada A; Hama A; Kanegane H; Kawakami K; Endo M; Hasegawa D; Kogawa K; Adachi S; Ikeda Y; Iwamoto S; Taga T; Kosaka Y; Kojima S; Hayashi Y; Ito E
    Blood; 2010 Nov; 116(22):4631-8. PubMed ID: 20729467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, cytogenetic, and molecular analyses of 17 neonates with transient abnormal myelopoiesis and nonconstitutional trisomy 21.
    Yuzawa K; Terui K; Toki T; Kanezaki R; Kobayashi A; Sato T; Kamio T; Kudo K; Sasaki S; Endo M; Ozono S; Nomura K; Ito E
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28188. PubMed ID: 32020774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
    Roberts I; Alford K; Hall G; Juban G; Richmond H; Norton A; Vallance G; Perkins K; Marchi E; McGowan S; Roy A; Cowan G; Anthony M; Gupta A; Ho J; Uthaya S; Curley A; Rasiah SV; Watts T; Nicholl R; Bedford-Russell A; Blumberg R; Thomas A; Gibson B; Halsey C; Lee PW; Godambe S; Sweeney C; Bhatnagar N; Goriely A; Campbell P; Vyas P;
    Blood; 2013 Dec; 122(24):3908-17. PubMed ID: 24021668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.
    Lum SH; Choong SS; Krishnan S; Mohamed Z; Ariffin H
    Singapore Med J; 2016 Jun; 57(6):320-4. PubMed ID: 27353457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and inexpensive high-resolution melting-based testing algorithm for diagnosis of transient abnormal myelopoiesis and myeloid leukemia of Down syndrome.
    Camargo R; de Castro Moreira Dos Santos A; Cândido Guido B; Lemos Mendanha Cavalcante L; Silva Dias AC; Mendonça de Pontes R; Magalhães Furtado F; Feitosa Salviano C; Tiziani V; Martins Córdoba JC; Quezado Magalhães IM
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29866. PubMed ID: 35731576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome.
    Garnett C; Cruz Hernandez D; Vyas P
    IUBMB Life; 2020 Jan; 72(1):119-130. PubMed ID: 31769932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
    Roy A; Roberts I; Vyas P
    Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
    Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis with hypereosinophilia causing transient abnormal myelopoiesis.
    Minakata S; Sakata N; Wada N; Konishi Y; Marutani S; Enya T; Nakagawa H; Wada H; Takemura T
    Pediatr Int; 2016 Nov; 58(11):1222-1225. PubMed ID: 27709778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
    Miyauchi J
    Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with Down syndrome.
    Chisholm KM; Rivetta CV; Heerema-McKenney A
    Ann Clin Lab Sci; 2015; 45(2):121-7. PubMed ID: 25887863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient abnormal myelopoiesis with extramedullary involvement in a down syndrome preemie leading to an unresponsive course despite chemotherapy.
    Geetha SD; Singh R; Shaham M; Cohen N; Sticco K
    Leuk Res Rep; 2023; 20():100381. PubMed ID: 37560406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive detection of GATA1 mutations using complementary DNA-based analysis for transient abnormal myelopoiesis associated with the Down syndrome.
    Mizuta S; Yamane N; Mononobe S; Watanabe A; Kitamura R; Takahara T; Matsushima C; Yoshida A; Okamoto S; Tanaka K; Iwai A; Ikegawa A; Wada T; Usami I; Maihara T; Komai T; Heike T; Nishida Y; Kobayashi K
    Int J Lab Hematol; 2022 Apr; 44(2):349-355. PubMed ID: 34761527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.